F512-0213 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-benzyl-2,3-dioxopiperazin-1-yl)acetamide

F512-0213 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-benzyl-2,3-dioxopiperazin-1-yl)acetamide
F512-0213 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-benzyl-2,3-dioxopiperazin-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F512-0213
N-(1,3-benzothiazol-2-yl)-2-(4-benzyl-2,3-dioxopiperazin-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F512-0213

Molecular Formula

C20H18N4O3S (C20 H18 N4 O3 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-2-(4-benzyl-2,3-dioxopiperazin-1-yl)acetamide

IUPAC name

N-(13-benzothiazol-2-yl)-2-(4-benzyl-23-dioxopiperazin-1-yl)acetamide

SMILES

O=C(CN(CCN(Cc1ccccc1)C1=O)C1=O)Nc1nc(cccc2)c2s1

InChI

InChI=1S/C20H18N4O3S/c25-17(22-20-21-15-8-4-5-9-16(15)28-20)13-24-11-10-23(18(26)19(24)27)12-14-6-2-1-3-7-14/h1-9H,10-13H2,(H,21,22,25)

InChI Key

CKUGTBKFGVDZCN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27170564

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

394.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.610

Distribution Coefficient, logD

2.610

Water Solubility, LogSw

-2.97

Polar Surface Area

66.194

Acid Dissociation Constant (pKa)

11.43

Base Dissociation Constant (pKb)

2.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

F512-0213 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F512-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F512-0213?
Check Price and Availability of F512-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F512-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F512-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F512-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F512-0213 available by request